Xeltis

Xeltis is a clinical-stage company developing medical devices enabling cardiovascular restoration. The company does that by leveraging breakthrough science to transform heart valve therapy.

The medical device platform comprises the first-ever bioabsorbable heart valves and blood vessels, designed to enable Endogenous Tissue Restoration (ETR): the natural restoration of the complex body part they replace upon implantation.